Febuxostat
- Product NDC
- 51407-293
- 11-digit product format
- 514070293
- Labeler code
- 51407
- Product ID
- 51407-293_15c4de3a-08ea-a228-e063-6394a90aafaf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Febuxostat
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA205414
- Marketing category
- ANDA
- Marketing start
- 2019-10-15
- Substance
- FEBUXOSTAT
- Active strength
- 40 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Febuxostat
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FEBUXOSTAT | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 101V0R1N2E |
| Rxcui | 834235, 834241 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51407-293-30 | Febuxostat | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51407-293 | FEBUXOSTAT TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240412_97a8c7fc-0a66-2ddc-e053-2a95a90ad313.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-293-30 | 51407029330 | 30 TABLET in 1 BOTTLE (51407-293-30) | 30 tablet | 2019-11-13 | 0000-00-00 | No | No | Current |